IP Library Granted Patent US 9,980,922
Granted Patent B2
US 9,980,922 · App. 15/331,706 · Granted May 29, 2018

Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders

Inventor: Dennis L. Gierhart (Chesterfield, MO)
Assignee: ZeaVision LLC
A61K31/047
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,980,922
App. No.
15/331,706
Granted
May 29, 2018
Kind
B2
Abstract

Oral formulations for promoting eye health, and in particular for preventing or treating macular degeneration, are disclosed, containing zeaxanthin, a carotenoid pigment, and at least two or more additional ocular-active nutrients selected from lipoic acid, omega-3 fatty acids, plant-derived compounds such as flavonoids, anthocyanins, or polyphenolics, taurine, carnitine, Coenzyme-Q10, carnosine, and nutrients that stimulate the production of glutathione. Processes are disclosed for identifying ocular-active nutrients that will interact in a synergistic and potentiating manner with zeaxanthin, to provide better and more effective protection, for eye health, than can be provided by zeaxanthin alone. Additional optional agents include zinc, vitamin E, and vitamin C.

Claims (16)

1. A nutrient formulation for oral ingestion for a daily dosage comprising:

a. at least 3 milligrams of zeaxanthin that is present in the 3R-3R′ stereoisomer form and is substantially free of meso-zeaxanthin stereoisomers;

b. zinc at a dosage that does not exceed 40 mg of elemental zinc;

c. at least two ocular-active nutrients selected from the group consisting of: (i) at least one tocopherol that provides anti-oxidant activity; (ii) vitamin C; (iii) lipoic acid; (iv) omega-3 fatty acids (EPA and DHA); and (v) coenzyme-Q10;

wherein the nutrient formulation is provided in the form selected from the group consisting of capsules, tablets, liquids, and powders for oral ingestion.

2. The nutrient formulation of claim 1 , further comprising plant-derived active agents.

3. The nutrient formulation of claim 2 , wherein the plant-derived active agents include flavonoids, bioflavonoids, anthocyanins, plant polyphenolics, and phytonutrients.

4. The nutrient formulation of claim 1 , further comprising taurine.

5. The nutrient formulation of claim 1 , further comprising carnitine.

6. The nutrient formulation of claim 1 , further comprising carnosine.

7. The nutrient formulation of claim 1 , further comprising glutathione boosters.

8. The nutrient formulation of claim 1 , wherein the omega-3 fatty acids are derived from fish oil.

9. The nutrient formulation of claim 1 , wherein the nutrient formulation is present in a form that provides sustained release over a span of at least 3 hours following ingestion.

10. The nutrient formulation of claim 1 , wherein the daily dosage of zeaxanthin is at least 10 milligrams.

11. The nutrient formulation of claim 1 , wherein the formulation is in the form of capsules containing oily carrier materials.

12. The nutrient formulation of claim 1 , wherein the at least one tocopherol includes vitamin E.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2016
From: GIERHART, DENNIS L.
To: ZEAVISION LLC
Reel/Frame 040093/0945 →
Continuity (3)
Continuation 14861803 · Sep 22, 2015
Continuation 10746403 · Dec 23, 2003
Related Publication 20170100347A1 · Apr 13, 2017